Article
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
4 May 2022
Abstract excerpt
The progress of genetic engineering in the 1970s brought about a paradigm shift in genome editing technology. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) system is a flexible means to target and modify particular DNA sequences in the genome. Several applications of CRISPR/Cas9 are presently being studied in cancer biology and oncology to provide vigorous...
Topics
Join the communities discussing this publication.
